RhumbLine Advisers’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,170
| Closed | -$19.7K | – | 4228 |
|
|
2025
Q1 | $19.7K | Sell |
16,170
-171,880
| -91% | -$210K | ﹤0.01% | 3741 |
|
|
2024
Q4 | $355K | Buy |
188,050
+174,896
| +1,330% | +$331K | ﹤0.01% | 2887 |
|
|
2024
Q3 | $70.2K | Buy |
13,154
+2,563
| +24% | +$13.7K | ﹤0.01% | 3606 |
|
|
2024
Q2 | $78.2K | Buy |
10,591
+945
| +10% | +$6.97K | ﹤0.01% | 3588 |
|
|
2024
Q1 | $115K | Sell |
9,646
-46
| -0.5% | -$549 | ﹤0.01% | 3396 |
|
|
2023
Q4 | $76.4K | Hold |
9,692
| – | – | ﹤0.01% | 3530 |
|
|
2023
Q3 | $42.8K | Sell |
9,692
-24
| -0.2% | -$106 | ﹤0.01% | 3679 |
|
|
2023
Q2 | $338K | Buy |
9,716
+799
| +9% | +$27.8K | ﹤0.01% | 2938 |
|
|
2023
Q1 | $194K | Buy |
8,917
+1,642
| +23% | +$35.7K | ﹤0.01% | 2743 |
|
|
2022
Q4 | $157K | Sell |
7,275
-9
| -0.1% | -$194 | ﹤0.01% | 2842 |
|
|
2022
Q3 | $178K | Buy |
7,284
+510
| +8% | +$12.5K | ﹤0.01% | 2921 |
|
|
2022
Q2 | $138K | Buy |
6,774
+2,142
| +46% | +$43.6K | ﹤0.01% | 3003 |
|
|
2022
Q1 | $165K | Buy |
4,632
+2,235
| +93% | +$79.6K | ﹤0.01% | 2797 |
|
|
2021
Q4 | $65K | Sell |
2,397
-103
| -4% | -$2.79K | ﹤0.01% | 2968 |
|
|
2021
Q3 | $108K | Buy |
2,500
+201
| +9% | +$8.68K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $115K | Buy |
+2,299
| New | +$115K | ﹤0.01% | 2962 |
|